← Back to Treatments
🏅 FDA Orphan Designation

Cordarone

Amiodarone HCl

Manufacturer: Wyeth-Ayerst Laboratories

Indicated for:
Inherited isolated arrhythmogenic ventricular dysplasia, biventricular variantOrphanCatecholaminergic polymorphic ventricular tachycardia

FDA-Approved Indications (2)

For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.

For initiation of treatment and prophylaxis of hemodynamically unstable ventricular tachycardia in patients refractory to other therapy

Population: all ages

Indications & Usage

For initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia in patients refractory to other therapy.

💙 Support Programs

View all →
Cordarone
Wyeth-Ayerst Laboratories

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.